Testosterone gel and method of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8741881
APP PUB NO 20130210791A1
SERIAL NO

13831231

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an improved transdermal hydroalcoholic testosterone gen formulation that provides, among other things, a desirable pharmacokinetic hormone profile, and methods of use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BESINS HEALTHCARE LUXEMBOURG SARL;UNIMED PHARMACEUTICALS, LLC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Malladi, Ramana Marietta, US 25 95
Stahlman, Jodi Smyrna, US 8 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00